daunorubicin has been researched along with Multiple Myeloma in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (25.00) | 18.7374 |
1990's | 8 (28.57) | 18.2507 |
2000's | 12 (42.86) | 29.6817 |
2010's | 1 (3.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cánovas, M; Cerezo, D; García-Peñarrubia, P; Martín-Orozco, E | 1 |
Lin, MF; Ouyang, GF | 1 |
Gabriel, DA; Giles, FJ; Gregory, SA; Mohrbacher, AF; Rusk, JM | 1 |
Eikel, D; Eucker, J; Gatz, F; Heider, U; Jakob, C; Jungclas, H; Mergenthaler, HG; Possinger, K; Sezer, O; Zavrski, I | 1 |
Anderson, KC; Hussein, MA | 1 |
Bennett, CL; Calhoun, EA | 1 |
Barros, JC; Bueno, ND; Chiattone, CS; Dulley, FL; Frota, MT; Hungria, VT; Macedo, MC; Mello, FG; Melo, LM; Mori, NS; Saboya, R; Silva, RL; Souza, CA; Sturaro, D | 1 |
Galski, H; Lazarovici, P; Nagler, A; Sivan, H | 1 |
Mahadevan, D | 1 |
Barge, R; Bertsch, U; Blau, I; Bos, GM; Breitkreutz, I; Breitkreuz, I; Croockewit, S; de Weerdt, O; Delforge, M; Duersen, U; Goldschmidt, H; Joosten, P; Lokhorst, HM; Martin, H; Naumann, R; Salwender, HJ; Schaafsma, R; Scheid, C; Schlenzka, J; Schmidt-Wolf, I; Sinnige, H; Sonneveld, P; van der Holt, B; van Marwijk-Kooy, M; van Oers, MH; Vellenga, E; Verhoef, G; Wijermans, P; Wittebol, S; Zweegman, S | 1 |
Cattan, AR; Maung, ZT | 1 |
Dyson, PG; Juttner, CA; Roberts, MM; To, LB; Willson, K | 1 |
Child, JA; Davies, FE; Fenton, JA; Morgan, GJ; Pratt, G; Proffitt, JA; Rawstron, AC; Smith, GM; Wiles, ME | 1 |
Bloem, AC; Lokhorst, HM; Roovers, DJ; van Vliet, M | 1 |
Muggia, FM | 1 |
Doria, G; Franchi, F; Konovalova, N; Pioli, C; Rossetti, R; Rossi Fanelli, F; Seminara, P; Tubani, L | 1 |
Gallagher, M; Garban, F; Jacob, MC; Jouvin-Marche, E; Marche, PN; Moine, A; Sotto, JJ | 1 |
Chura, CM; Maddrey, WC; Roll, FJ; Wands, JR | 1 |
Ascari, E; Danova, M; Giordano, M; Invernizzi, R; Luoni, R; Rastaldi, MP; Riccardi, A; Ucci, G; Zambelli, ML | 1 |
Kosaka, M; Miyamoto, Y; Mizuguchi, T; Tamura, K | 1 |
Abdulkadyrov, KM; Bessmel'tsev, SS; Liubimova, NIu | 1 |
Abdulkadyrov, KM; Bessmel'tsev, SS; Katsadze, IuL | 1 |
Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Selby, PJ; Zuiable, A | 1 |
Capnist, G; Chisesi, T; de Dominicis, E; Dini, E | 1 |
Eridani, S; Pearson, TC; Singh, AK; Slater, NG | 1 |
Frei, E; Goldin, A; Schabel, FM | 1 |
Parker, AC | 1 |
Hawk, IA; Levy, CC; Russell, DH; Schimpff, SC | 1 |
3 review(s) available for daunorubicin and Multiple Myeloma
Article | Year |
---|---|
Role of liposomal anthracyclines in the treatment of multiple myeloma.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Daunorubicin; Dexamethasone; Doxorubicin; Humans; Liposomes; Multiple Myeloma; Vincristine | 2004 |
Pharmacoeconomics of liposomal anthracycline therapy.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Costs and Cost Analysis; Daunorubicin; Doxorubicin; Female; Humans; Liposomes; Male; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi | 2004 |
Liposomal encapsulated anthracyclines: new therapeutic horizons.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Liposomes; Lymphoma; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi | 2001 |
6 trial(s) available for daunorubicin and Multiple Myeloma
Article | Year |
---|---|
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Daunorubicin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Liposomes; Male; Middle Aged; Multiple Myeloma | 2002 |
Liposomal daunorubicin (DaunoXome) in multiple myeloma: a modified VAD regimen using short-term infusion.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dexamethasone; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Liposomes; Male; Middle Aged; Multiple Myeloma; Vincristine | 2003 |
Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma--the DD Protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dexamethasone; Drug Administration Schedule; Female; Humans; Liposomes; Male; Middle Aged; Multiple Myeloma; Paraproteins; Prospective Studies; Treatment Outcome | 2005 |
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Male; Medical Oncology; Middle Aged; Multiple Myeloma; Remission Induction; Thalidomide; Thioguanine; Treatment Outcome; Vincristine | 2008 |
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Cell Differentiation; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Multiple Myeloma; Ovarian Neoplasms; Platelet Count; Thioguanine; Time Factors | 1996 |
Activity of a nitroxylated analog of daunorubicin, ruboxyl, in B-lymphoproliferative disorders.
Topics: Aged; Aged, 80 and over; Animals; Antibiotics, Antineoplastic; B-Lymphocytes; Cells, Cultured; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Lymphocyte Count; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C57BL; Middle Aged; Multiple Myeloma; Pilot Projects; Remission Induction; Spleen; T-Lymphocytes; Waldenstrom Macroglobulinemia | 2001 |
19 other study(ies) available for daunorubicin and Multiple Myeloma
Article | Year |
---|---|
Collateral sensitivity to cold stress and differential BCL-2 family expression in new daunomycin-resistant lymphoblastoid cell lines.
Topics: Antibiotics, Antineoplastic; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Proliferation; Cold Temperature; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Stress, Physiological; Tumor Cells, Cultured | 2015 |
Combined effects of bortezomib and daunorubicin on multiple myeloma cell KM3 in vitro.
Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Humans; Inhibitory Concentration 50; Multiple Myeloma; Pyrazines | 2009 |
In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles | 2006 |
Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies?
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles | 2006 |
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Coloring Agents; Daunorubicin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Idarubicin; Leukemia, Experimental; Male; Mice; Mice, SCID; Multiple Myeloma; Tetrazolium Salts; Toxicity Tests; Tumor Cells, Cultured | 1996 |
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Carriers; Humans; Liposomes; Middle Aged; Multiple Myeloma; Treatment Outcome; Tumor Cells, Cultured | 1998 |
Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Idarubicin; Multiple Myeloma; Tumor Cells, Cultured; Verapamil | 1999 |
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and blood.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood; Blood Cells; Carmustine; CD8-Positive T-Lymphocytes; Clone Cells; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Female; Graft Survival; Graft vs Host Reaction; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunotherapy; Leukemia, Myeloid; Male; Middle Aged; Minisatellite Repeats; Multiple Myeloma; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Skin; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2000 |
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
Topics: Adolescent; Adult; Antibodies, Viral; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Hepatitis B Antigens; Humans; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloproliferative Disorders; Prednisone; Procarbazine; Vincristine | 1975 |
[p170 in multiple myeloma and acute leukemia].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Colonic Neoplasms; Cytarabine; Daunorubicin; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Peptichemio; Plasma Cells; Prednisone; Remission Induction; Survival Rate; Tumor Cells, Cultured; Vincristine | 1991 |
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Colony-Stimulating Factors; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Vincristine | 1990 |
[Immunological and rheological disorders in multiple myeloma patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Chronic Disease; Cyclophosphamide; Daunorubicin; Female; Heart Failure; Humans; Immunity, Cellular; Kidney Failure, Chronic; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Vincristine | 1991 |
[The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Blood Viscosity; Chronic Disease; Cyclophosphamide; Daunorubicin; Drug Evaluation; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrogen Mustard Compounds; Prednisolone; Vincristine | 1991 |
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Survival; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Verapamil; Vincristine | 1989 |
A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged; Multiple Myeloma; Nausea; Thrombocytopenia | 1988 |
Intravenous and oral demethoxydaunorubicin (NSC 256-439) in the treatment of acute leukemia and lymphoma: a pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Antineoplastic Agents; Daunorubicin; Female; Humans; Idarubicin; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pilot Projects | 1985 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine | 1974 |
A case of acute myelomonocytic leukaemia associated with myelomatosis.
Topics: Aged; Autopsy; Blood Cell Count; Blood Protein Disorders; Blood Protein Electrophoresis; Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; Humans; Immunoelectrophoresis; Immunoglobulin G; Leukemia, Myeloid; Male; Melphalan; Multiple Myeloma; Prednisone | 1973 |
Urinary polyamines in cancer patients.
Topics: Brain Neoplasms; Chemistry, Clinical; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Polyamines; Pregnancy; Remission, Spontaneous; Spermidine; Spermine; Teratoma | 1971 |